InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,895.64
(
0.43%
)
US TECH 100
20,029.20
(
0.84%
)
Dow Jones
43,413.43
(
-0.07%
)
Brent Oil
72.89
(
3.08%
)
Bitcoin
91,157.06
(
1.44%
)
Post# of 403773
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

To infinity and beyond!

Send PM Follow Ignore
Followers 35
Posts 6308
Boards Moderated 0
Alias Born 02/09/2015

To infinity and beyond!

Re: BonelessCat post# 150261

Tuesday, 06/07/2016 2:36:08 PM

Tuesday, June 07, 2016 2:36:08 PM

Post# of 403773
You are kidding, right?

If apr-246 has no efficacy then the phase 2 part of the 1b/2 is cancelled And then there is no ASCO presentation yesterday by Aprea.

And if K 1B shows no efficacy the trial will be over.

Surely you are not suggesting they would move on with a Kevetrin trial that shows no promise in 1B? It must demonstrate efficacy in 1B

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent IPIX News
More IPIX News
InvestorsHub NewsWire

FEATURED Are we about to see a comeback? Steakholder Foods Charges Forward with New Commitments from Multiple International Players as it Transitions to Revenue Generation • Nov 18, 2024 11:56 AM

FEATURED North Bay Resources Announces Production of Gold Concentrate and Refinery Shipment at Bishop Gold Mill, California • Nov 18, 2024 9:00 AM

One World Products Sets New Standards in Sustainability With Strategic Hemp Innovations • OWPC • Nov 18, 2024 7:54 AM

Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM

HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM

Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM

Start posting your company's news
Only $200 per official company press release!